期刊文献+

^(18)F-FDG PET/CT在探测卵巢癌术后复发和转移中的价值 被引量:15

Value of ^(18)F-FDG PET/CT Imaging in Detection of Postoperative Recurrent or Metastasis of Ovarian Cancer
下载PDF
导出
摘要 [目的]评价18F-FDG PET/CT显像在探测卵巢癌术后复发病灶中的应用价值。[方法]采用仪器为Siemens Biograph Sensation 16 PET/CT,43例卵巢癌术后患者禁食4~6h,静脉注射18F-FDG60min后进行PET/CT检查,采集方式为3D模式。PET/CT图像结果与血清CA125、B超及CT或MRI影像学资料进行比较。并与手术病理或临床随访结果比较判断其诊断的准确性。[结果]FDG PET/CT诊断卵巢癌复发的灵敏度、特异性和准确性分别为92.3%、100%和93.0%。血清CA125水平与FDG PET结果有一定相关性,33例CA125升高患者中31例PET显像阳性,10例CA125正常水平患者中仅有5例PET显像阳性。[结论]当常规影像学检查阴性或可疑时,PET/CT显像对卵巢癌复发的检测具有较高的灵敏度和准确性,特别术后患者CA125升高的情况下,FDG PET/CT有助于探测隐匿性复发或转移病灶,指导进一步的治疗。 [Purpose] To evaluate the value of integrated positron emission tomography(PET)and computed tomography(CT)for depiction of recurrence ovarian carcinoma after surgery.[Methods] The model of PET/CT scanner we used is Siemens Biograph Sensation 16.Forty-three women who had previously undergone surgery for ovarian cancer were included.The patients received 18F-FDG intravenously after fasting for 4 to 6 hours.3D whole body PET/CT scans were acquired 60 min after injection.PET/CT imaging results were compared with the results of serum CA125 levels and ultrasound,CT or MRI conventional imaging.PET/CT results were compared to histologic examination after surgery and clinical follow-up to determine the diagnostic accuracy of PET/CT in the evaluation of disease status.[Results]The overall sensitivity,specificity,accuracy of PET/CT were 92.3%,100%,93.0% respectively.There was a positive correlation between serum CA125 and positive result of FDG PET/CT.PET/CT could detect recurrent lesions in 31 of 33 patients in whom increased serum CA125 level.Among the 10 patients with serum CA125 in normal range,PET/CT correctly detected recurretn foci in 5 patients.[Conclusion]PET/CT depicts recurrent ovarian carciooma with a high sensitivity and accuracy when conventional imaging is inconclusive or negative,especially in patients with increased CA125 levels.FDG PET/CT image can help to detect occult metastasis and direct further treatment to the precise site of tumor recurrence.
出处 《中国肿瘤》 CAS 2007年第3期187-189,共3页 China Cancer
关键词 卵巢肿瘤 复发 转移 PET/CT ovarian neoplasms recurrence neoplasm metastasis PET/CT
  • 相关文献

参考文献10

  • 1Schroder W,Zimny M,Rudlowski U,et al.The role of 18F-fluoro-deoxyglucose positron emission tomography(^18F-FDG PET) in diagnosis of ovarian cancer[J].Int J Gynecol Cancer,1999,9(2):117-122.
  • 2Nakamoto Y,Saga T,Ishimori T,et al.Clinical value of positron emission tomography with FDG for recurrent ovarian cancer[J].AJR,2001,176(6):1449-1454.
  • 3Cho SM,Ha HK,Byun JY,et al.Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer[J].AJR,2002,179(2):391-395.
  • 4赵军,林祥通.关于PET/CT临床应用的若干问题[J].中华核医学杂志,2005,25(2):69-71. 被引量:17
  • 5Zhao J,Lin XT,Wu XH,et al.Detection of occult metastasis of recurrent ovarian cancer using integrated FDG PET/CT[J].J Nucl Med,2005,46(suppl 5):196P.
  • 6董孟杰,林祥通,赵军.PET-CT在卵巢癌中的临床应用价值[J].国外医学(放射医学核医学分册),2005,29(5):209-213. 被引量:7
  • 7Makhija S,Howden N,Edwards R,et al.Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma:a retrospective review[J].Gynecol Oncol,2002,85(l):53-58.
  • 8Nanni C,Rubello D,Farsad M,et al.18F-FDG PET/CT in the evaluation of recurrent ovarian cancer:a prospective study on forty-one patients[J].Eur J Surg Oncol,2005,31(7):792-797.
  • 9Hauth EA,Antoch G,Stattaus J,et al.Evaluation of integrated whole-body PET/CT in the detection of recurrent ovarian cancer[J].Eur J Radiol,2005,56(2):263-268.
  • 10Smith GT,Hubner KF,McDonald T,et al.Cost analysis of FDG PET for managing patients with ovarian cancer[J].Clin Positron Imaging,1999,2(2):63-70.

二级参考文献41

  • 1孙晓蓉,邢力刚,于金明,付政,马莉,赵书强,陈鲁生,李文武,杨国仁.肺部肿瘤PET/CT同机图像融合精度研究[J].中华核医学杂志,2004,24(5):302-304. 被引量:11
  • 2Nakamoto Y, Tatsumi M, Cohade C, et al. Accuracy of image fusion of normal upper abdominal organs visualized with PET/CT. Eur J Nucl Med Mol Imaging, 2003, 30: 597-602.
  • 3Nakamoto Y, Osman M, Cohade C, etal. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuationcorrected images. J Nucl Med, 2002, 43: 1137-1143.
  • 4Goerres GW, Ziegler SI, Burger C, et al. Artifacts at PET and PET/CT caused by metallic hip prosthetic material. Radiology, 2003, 226: 577-584.
  • 5Nakamoto Y, Chin BB, Kraitchman DL, et al. Effects of nonioruc intravenous contrast agents at PET/CT imaging: phantom and canine studies.Radiology, 2003, 227: 817-824.
  • 6Antoch G, Freudenberg LS, Egelhof T, et al. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med, 2002, 43: 1339-1342.
  • 7Erdi YE, Nehmeh SA, PanT, etal. The CT motion quantitation of lung lesions and its impact on PET measured SUVs. J Nucl Med, 2004, 45:1287-1292.
  • 8Boucher L, Rodrigue S, Lecomte R, et al. Respiratory gating for 3-dimensional PET of the thorax: feasibility and initial results. J Nucl Med,2004, 45: 214-219.
  • 9Osman MM, Sattah MV, Kayyat NM, etal. Bone metastases from nonsmall cell lung cancer: prevalence and patterns detected by true whole body ^18F-FDG PET. J Nucl Med, 2004, 45 Suppl: 25p-26p.
  • 10Vogel WV, Oyen WJG, Barentsz JO, et al. PET/CT: panacea, redundancy, or something in between? J Nucl Med, 2004, 45: 15S-24S.

共引文献20

同被引文献113

引证文献15

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部